Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Accenture Plc (ACN), Navigant Consulting, Inc. (NCI), CGI Group Inc. (USA) (GIB): 3 Names to Make Your Business Profitable

Page 1 of 3

As the complexity in the business world increases, government regulated industries find it more difficult to maintain profitability and outsourcing becomes more convenient, and as a result, consulting companies seem poised for growth. In this field, three big names should be taken into account by fundamental, long-term investors: Accenture Plc (NYSE:ACN), Navigant Consulting, Inc. (NYSE:NCI), and CGI Group Inc. (USA) (NYSE:GIB).

Accenture Plc (NYSE:ACN): Strong position in the market

Accenture Plc (NYSE:ACN)

Accenture Plc (NYSE:ACN) is one of the main go-to names in the management and IT consulting business. With one of the biggest global operations in the field, companies think of Accenture when looking for unmatched capabilities and international presence, alongside its knowledge and expertise.

One of the keys to this firm’s success is its customer relations; as service providers, Accenture Plc (NYSE:ACN) establishes close and productive relationships with its clients, which trust it not only with sensitive information, but also with planning for the future. Given this situation, the stickiness of its client base is outstanding. Furthermore, the company has proven proactive, efficient, and effective. Therefore, new clients constantly feel attracted by its value proposal.

But, Accenture Plc (NYSE:ACN) is not only about consulting, but also about solving issues. As such, it has also become an outsourcing firm that has allowed other companies to save money by establishing operations in cheap-labor (but educated) countries like India, the Philippines, and Argentina. Its early incursion in this field has helped it generate a steady cash flow, as outsourcing, unlike consulting services, is usually stable and long-term, or at least recurring. By establishing its business in various countries, the firm is able to compete with offshore consultants and IT service companies that face lower costs than U.S.-based enterprises.

Although its stock trades a little above the industry average, at 19.4 times P/E (versus the 19.1 mean), I would recommend buying Accenture’s shares. With an industry leading human capital and profiting from other companies’ disruptive innovation without incurring in the costs and risks implied, its financials are among the strongest in the segment. Poised to deliver consistent growth — although not at the highest rates but rather around 11.5% annually — this is a good company for your retirement portfolio as a deterioration in its market conditions doesn’t seem anywhere near — actually, the situation is the opposite.

Navigant Consulting, Inc. (NYSE:NCI): A wide product portfolio

Navigant Consulting, Inc. (NYSE:NCI) is another interesting firm in the industry that counts a wide customer and consultant base (roughly 1,800 advisers). Formerly known as The Metzler Group, Navigant Consulting, Inc. (NYSE:NCI) is an established name in the specialty consulting segment, particularly among highly regulated or structurally changing industries, like energy, financial, and healthcare sectors.

With an expected EPS average annual growth rate of 12.5% for years to come, the firm offers compelling long-term prospects. I believe that the firm will outperform its peers based on its large consultant base and its long-standing, sticky, customer relations.

Although it focuses on litigation consulting, its product portfolio is quite wide, comprising four segments: (1) Disputes, Investigations & Economics, (2) Financial, Risk & Compliance Advisory, (3) Healthcare, and (4) Energy.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!